Crossmark

Effect of vitamin D3 on antiphospholipid antibodies in hospitalized patients with moderate to severe COVID-19

Crossref DOI link: https://doi.org/10.1016/j.clinsp.2024.100474

Published Print: 2024-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Sales, Lucas P. http://orcid.org/0000-0003-2439-2240
Souza, Lucas V.B.

Fernandes, Alan L. http://orcid.org/0000-0002-6786-3922
Murai, Igor H. http://orcid.org/0000-0002-0077-5004
Santos, Mayara D. http://orcid.org/0000-0001-9363-7411
Vendramini, Margarete B.G. http://orcid.org/0000-0001-8732-6609
Oliveira, Ricardo M.

Figueiredo, Camille P. http://orcid.org/0000-0003-1102-8175
Caparbo, Valéria F. http://orcid.org/0000-0002-6606-8628
Gualano, Bruno http://orcid.org/0000-0001-7100-8681
Pereira, Rosa M.R. http://orcid.org/0000-0002-3723-5028
License Information

Text and Data Mining valid from 2024-01-01

Text and Data Mining valid from 2024-01-01

Version of Record valid from 2024-07-26
More Information

This article is maintained by: Elsevier

Article Title: Effect of vitamin D3 on antiphospholipid antibodies in hospitalized patients with moderate to severe COVID-19

Journal Title: Clinics

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.clinsp.2024.100474

Content Type: article

Copyright: © 2024 HCFMUSP. Published by Elsevier España, S.L.U.